What are the clinical considerations when transitioning a patient from semaglutide to tirzepatide in terms of dosing and titration?

Transitioning from semaglutide to tirzepatide involves following specific dosing schedules and monitoring insulin needs, with potential reductions in insulin dosing due to tirzepatide's effects. Close monitoring for side effects and adjustments based on individual patient response are critical considerations.